Trials / Completed
CompletedNCT05112250
IVL for Stent Underexpantsion
Intravascular Lithotripsy for the Treatment of Stent Underexpansion: the Multicenter IVL-DRAGON Registry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 62 (actual)
- Sponsor
- Medical University of Silesia · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The IVL-Dragon Registry was a multicenter study that enrolled consecutive patients with stent underexpansion treated with IVL in high-volume PCI centers. The primary efficacy endpoint was clinical success, defined as a reduction of stent underexpansion to \<30% with no evidence of in-hospital device-oriented composite end point (DOCE) (defined as a composite of cardiac death, target lesion revascularization, and target vessel myocardial infarction).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Percutaneous Coronary Intervention | Intravascular lithotripsy (IVL) |
Timeline
- Start date
- 2019-11-01
- Primary completion
- 2021-04-01
- Completion
- 2021-04-01
- First posted
- 2021-11-08
- Last updated
- 2021-11-08
Locations
16 sites across 1 country: Poland
Source: ClinicalTrials.gov record NCT05112250. Inclusion in this directory is not an endorsement.